There are many studies suggesting that MEK5 plays a critical role in cancer occurrence and development, such as prostate cancer [18], breast cancer [19], hepatocellular cancer [20] and lung cancer [21]. This evidence concerns the gene MAP2K5 and prostate carcinoma.